Delivery Order SPE2DR25D1109-SPE2DR26FFH2P
Award Date 12/2/25
Potential Completion Date 12/3/25
Potential Value $27K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) valued at $3,279.20 under a firm fixed price contract. This non-set-aside award was executed on December 12, 2025, with a completion date of December 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) valued at $13,841.99 under a firm fixed-price contract type. The award was made on August 22, 2025, with an ultimate completion date of August 25, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $28,835.02 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets in quantities of 30, with an ultimate completion date of November 13, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $9,465.80 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on December 11, 2025, with an ultimate completion date of December 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military...
- The Defense Logistics Agency awarded a delivery order valued at $10,854.26 to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-count unit of use packaging) on December 9, 2025, with completion expected by December 10, 2025. This firm fixed-price delivery order is non-competitive and represents a single transaction under the company's existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) valued at $12,603.88 under a firm fixed-price contract. The award was made on December 3, 2025, with an ultimate completion date of December 4, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp will perform this order from its corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $41,291.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) with a completion date of December 9, 2025. The award, issued on December 8, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $4,403.45 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on December 3, 2025, with a completion date of December 4, 2025. This firm fixed-price, non-set-aside delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count unit of use packaging) valued at $21,040.94, with an ultimate completion date of June 30, 2025. This non-set-aside award represents a competitive procurement supporting the agency's pharmaceutical supply requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $10,040.64 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) with a firm fixed price structure. This non-set-aside competitive award was issued on September 26, 2025, with an ultimate completion date of September 29, 2025. The contract is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor serving...